|
COMMERCE BUSINESS DAILY ISSUE OF FEBRUARY 29,2000 PSA#2546National Institute of Diabetes, Digestive & Kidney Diseases (NIDDK),
Acquisition Management Branch, Natcher Building, 45 Center Dr., MSC
6600, Room 6AN32, Bethesda, Maryland 20892-6600 99 -- CUSTOM OLIGONUCLEOTIDE SYNTHESIS TO INCLUDE PRIMERS SOL
NIH-NIDDK-00-538 DUE 032000 POC Desiree Kelly, Purchasing Agent
301-594-7731 The National Institutes of Health (NIH), National
Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has a
requirement to purchase Custom Oligonucleotide Synthesis to include
primers from Applied Biosystems, 850 Lincoln Centre Drive, Foster City,
CA 94494. The following Custom Oligonucleotide is required for this
requirement. 1)TaqMan Probe 5,000-6,000 pmols (5'-Fluorescent label:
6-FAM, VIC or TET, 3-label: Tamra, 2) TaqMan Probe 15,000-25,000 pmols
(5'-Fluorescent label: 6-FAM, VIC or TET.3'label: Tamra, 3) TaqMan
Probe 50,000-100,000 pmols ( 5'-Fluorscent label: 6-FAM, VIC or
TET,3'label: TAMRA, 4) turbo TaqMan Probe 5,000-6,000 pmols
(5'Fluorescent label: 6-FAM, VIC or TET, 3'label: TAMRA,5) turbo TaqMan
Probe 15,000-25,000 pmols ( 5'-Fluorescent label: 6-FAM, VIC or TET,
3'-label: TAMRA,6) turbo TaqMan Probe 50,000-1000,000 pmols
(5'-Fluorrsescent label: 6-FAM, VIC or TET. 3'-label: TAMRA), 7)
Sequence Detection Primers (minimum 4,000 pmols purified for sequencing
detection,8) Sequence Detection Primers (minimum 40,000 pmols purified
for sequence detection,9) Sequence Detection Primers (minimum 130,000
pmols purified for sequence detection, 10) TaqMan Universal PCR Master
Mix and 10-Pack, 11) TaqMan Universal PCR Master Mix. The Institute
intends to purchase these biological by other than full and open
competition from Applied Biosystems. Interested vendors may identify in
writing their interest with a capability statement to the Contracting
Office prior to the closing date of this notice. This notice of intent
is not a request for competitive proposals, however, all responses
received before the closing date of this announcement will be
considered by the Government. A determination by the Government not to
compete this proposal acquisition is based upon responses to this
notice and is solely within the discretion of the Government.
Information received will be considered solely for the purpose of
determining whether to conduct a competitive procurement. It is
anticipated that Request for Quotation (RFQ) NIH-NIDDK-00-538 will be
available fifteen (15) days after the publication date of this
synopsis. Receipt of quotations will be due ten days (10) after the
release of the RFQ. The anticipated award date is March 21, 2000.
Request for copies of the RFQ must be in writing and may be faxed to
301-480-4226. Quotations must be submitted in writing to the National
Institute of Diabetes and Digestive and Kidney Diseases 6705 Rockledge
Drive, Building One, Room 8048, Bethesda, MD 20817-7973 Attention:
Desiree Kelly. Fax quotations will only be accepted if dated and signed
by an authorized company representative. Posted 02/25/00 (W-SN428652).
(0056) Loren Data Corp. http://www.ld.com (SYN# 0141 20000229\99-0001.SOL)
99 - Miscellaneous Index Page
|
|